075B4ZZ
Destruction Lymphatic, Mesenteric to No Qualifier with No Device, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | 5 Destruction |
| Body Part | B Lymphatic, Mesenteric |
| Approach | 4 Percutaneous Endoscopic |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures in the lymphatic and hemic systems eliminate abnormal tissue in place, using heat, cold, chemicals, or other energy sources rather than physically cutting it out. In practice this most often means sclerotherapy or ablation of lymphatic malformations, cystic hygromas, or enlarged lymph nodes, where injecting or applying an agent causes the abnormal tissue to shrink and scar down.
This approach is favored when surgical removal would be difficult or risky, such as malformations located near major blood vessels or nerves, or in children where minimizing surgical trauma matters. It can also be used to manage lymphoceles that have not responded to simple drainage.
Because the tissue is destroyed rather than removed, there is nothing sent to pathology, which is a key practical difference from excisional approaches.
Anatomy & Axis Detail
Lymphatic, Mesenteric
Mesenteric lymph nodes are scattered within the mesentery supporting the small and large bowel, filtering lymph draining the intestinal wall and playing a key role in gut-associated immune surveillance. When these nodes harbor infection, inflammatory disease, or tumor deposits that the surgeon chooses to ablate rather than excise, Destruction is coded, typically achieved through cautery, laser, or cryoablation applied directly to the nodal tissue during an open or laparoscopic approach. Because the mesentery contains major vascular arcades supplying the bowel, care in energy application is essential to avoid compromising intestinal blood flow. The documentation should reflect that the nodal tissue was obliterated in situ, with no specimen removed for separate pathologic evaluation.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Coding & Documentation
Coders should assign Destruction when the documentation describes obliterating tissue in place, through sclerosing agents, laser, radiofrequency, or similar means, with no specimen extracted from the body. The specific agent or energy source used should be reflected in the approach and, where applicable, the qualifier.
A common error is coding a sclerotherapy injection as Introduction of a substance rather than Destruction of the target tissue, since both involve injecting an agent but only one is aimed at eradicating the lymphatic structure itself. Reviewing physician intent and the described tissue effect, rather than just the act of injection, resolves this distinction.